These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 16542178)
1. Cyclin D1 protein expression in human thyroid gland and thyroid cancer. Temmim L; Ebraheem AK; Baker H; Sinowatz F Anat Histol Embryol; 2006 Apr; 35(2):125-9. PubMed ID: 16542178 [TBL] [Abstract][Full Text] [Related]
2. The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer. Wang S; Lloyd RV; Hutzler MJ; Safran MS; Patwardhan NA; Khan A Mod Pathol; 2000 Aug; 13(8):882-7. PubMed ID: 10955455 [TBL] [Abstract][Full Text] [Related]
4. Expression of cell-cycle regulators (cyclin D1, cyclin E, p27kip1, p57kip2) in papillary thyroid carcinoma. Lee SH; Lee JK; Jin SM; Lee KC; Sohn JH; Chae SW; Kim DH Otolaryngol Head Neck Surg; 2010 Mar; 142(3):332-7. PubMed ID: 20172376 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions. Saiz AD; Olvera M; Rezk S; Florentine BA; McCourty A; Brynes RK J Pathol; 2002 Oct; 198(2):157-62. PubMed ID: 12237874 [TBL] [Abstract][Full Text] [Related]
6. Assessment of cyclin D1 gene expression as a prognostic factor in benign and malignant thyroid lesions. Brzeziańska E; Cyniak-Magierska A; Sporny S; Pastuszak-Lewandoska D; Lewiński A Neuro Endocrinol Lett; 2007 Aug; 28(4):341-50. PubMed ID: 17693985 [TBL] [Abstract][Full Text] [Related]
7. Analysis of cyclin D1 and retinoblastoma protein immunoreactivity in follicular thyroid tumors. Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Jarzab B; Satacińska-Los E; Kulig A; Włoch J Pol J Pathol; 2005; 56(1):27-35. PubMed ID: 15921011 [TBL] [Abstract][Full Text] [Related]
8. Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer. Melck A; Masoudi H; Griffith OL; Rajput A; Wilkins G; Bugis S; Jones SJ; Wiseman SM Ann Surg Oncol; 2007 Dec; 14(12):3403-11. PubMed ID: 17882495 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of p27/kip1 expression in thyroid carcinoma. Resnick MB; Schacter P; Finkelstein Y; Kellner Y; Cohen O Mod Pathol; 1998 Aug; 11(8):735-9. PubMed ID: 9720501 [TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 overexpression in thyroid papillary microcarcinoma: its association with tumour size and aberrant beta-catenin expression. Lantsov D; Meirmanov S; Nakashima M; Kondo H; Saenko V; Naruke Y; Namba H; Ito M; Abrosimov A; Lushnikov E; Sekine I; Yamashita Sh Histopathology; 2005 Sep; 47(3):248-56. PubMed ID: 16115225 [TBL] [Abstract][Full Text] [Related]
11. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation. Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294 [TBL] [Abstract][Full Text] [Related]
12. The role of cell cycle regulatory proteins, cyclin D1, cyclin E, and p27 in thyroid carcinogenesis. Wang S; Wuu J; Savas L; Patwardhan N; Khan A Hum Pathol; 1998 Nov; 29(11):1304-9. PubMed ID: 9824112 [TBL] [Abstract][Full Text] [Related]
13. Association of nuclear, cytoplasmic expression of galectin-3 with beta-catenin/Wnt-pathway activation in thyroid carcinoma. Weinberger PM; Adam BL; Gourin CG; Moretz WH; Bollag RJ; Wang BY; Liu Z; Lee JR; Terris DJ Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):503-10. PubMed ID: 17515507 [TBL] [Abstract][Full Text] [Related]
14. Survivin and cyclin D1 are jointly expressed in thyroid papillary carcinoma and microcarcinoma. Antonaci A; Consorti F; Mardente S; Natalizi S; Giovannone G; Della Rocca C Oncol Rep; 2008 Jul; 20(1):63-7. PubMed ID: 18575719 [TBL] [Abstract][Full Text] [Related]
15. Expression of the melanoma-associated antigen is associated with progression of human thyroid cancer. Cheng S; Liu W; Mercado M; Ezzat S; Asa SL Endocr Relat Cancer; 2009 Jun; 16(2):455-66. PubMed ID: 19261683 [TBL] [Abstract][Full Text] [Related]
16. Expression of CD44 and cyclin D1 in fine needle aspiration cytology of papillary thyroid carcinoma. Kim JY; Cho H; Rhee BD; Kim HY Acta Cytol; 2002; 46(4):679-83. PubMed ID: 12146030 [TBL] [Abstract][Full Text] [Related]
17. Altered expression of cell cycle regulatory proteins in benign and malignant bone and soft tissue neoplasms. Bui MM; Bagui TK; Boulware DC; Letson DG; Nasir A; Kaiser HE; Pledger WJ; Coppola D In Vivo; 2007; 21(5):729-37. PubMed ID: 18019405 [TBL] [Abstract][Full Text] [Related]
18. Expression of cell cycle biomarkers and telomere length in papillary thyroid carcinoma: a comparative study between radiation-associated and spontaneous cancers. Achille M; Boukheris H; Caillou B; Talbot M; de Vathaire F; Sabatier L; Desmaze C; Schlumberger M; Soria JC Am J Clin Oncol; 2009 Feb; 32(1):1-8. PubMed ID: 19194115 [TBL] [Abstract][Full Text] [Related]
19. Differential (Ha-, K- and N-) ras p21 expression in benign and malignant human thyroid tumors: an immunohistochemical study. Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Nakamura S; Hashimoto T Anticancer Res; 1995; 15(3):755-9. PubMed ID: 7645954 [TBL] [Abstract][Full Text] [Related]
20. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features. Ioachim E Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]